Replies to post #480030 on Anavex Life Sciences Corp (AVXL)

[Doc328]

where did the MAA application indicate it is for full authorization not conditional? ChatGPT thinks it could be either full or conditional—will be determined by the EMA during their review process.,

At the Aug 6, 2024 CC, Missling said "The initiated process for submitting a Marketing Authorization application, MAA, to the European Medicine Agency, EMA, under the Centralized Procedure is underway with full regulatory submission of blarcamesine expected in Q4 of 2024"